Fig. 4From: A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trialPostoperative laboratory tests. Including a ALT (U/L), b AST (U/L), c ALB (g/L), d TBIL (μmol/L), e ALP (U/L), f γ-GGT (U/L), g CREAT (μmol/L), and h BUN (mmol/L). (The data are presented as the mean ± SEM; *p < 0.05)Back to article page